University of Florida Study Finds Many Pregnant Women Take Drugs That May Harm Their Unborn Children

In a study of more than 3 million pregnancies, University of Florida researchers found 1 in 16 women were exposed to harmful teratogenic drugs — medications that can cause pregnancy loss, birth defects, and other health problems for the unborn child.

Researchers investigated more than 200 teratogenic drugs and evaluated their exposure among 3.4 million pregnancies identified in a national private insurance database from 2006 to 2017. Prenatal exposure was defined by the mother taking at least one teratogenic drug during pregnancy. A teratogen is a substance that interferes with the normal development of a fetus. Hundreds of such drugs have been identified, including medications to treat seizures, migraines, obesity, acne, hypertension, bipolar disease, and cancer.

Using teratology drug databases, the medications were separated into two classes based upon their known teratogenic effect. About 140 drugs were known to have definite teratogenic effects, and another 65 were identified as having potential teratogenic effects. The proportion of pregnancies with exposure to definite teratogens decreased slightly over the 12-year study period from 1.9 percent to 1.2 percent, while exposures for potential teratogens increased from 3.4 percent to 5.3 percent.

“While declining exposure rates among teratogenic drugs with definite risk are encouraging, the rising prenatal exposure to drugs with potential risk calls for more assessment,” said Almut Winterstein, an author of the study and distinguished professor and chair of the department of pharmaceutical outcomes and policy in the University of Florida College of Pharmacy. “To have 1 in 16 women and their unborn baby exposed to a teratogenic medication is simply too high, and we must identify strategies to improve pregnancy outcomes.

“If you are pregnant, planning to become pregnant, or sexually active you must understand the risks involved with taking teratogenic drugs,” added Dr. Winterstein. “Talk with your provider about your medications and review drug labels to ensure the medications you are taking are not putting your unborn child at risk.”

The full study “Prenatal Exposure to Teratogenic Medications in the Era of Risk Evaluation and Mitigation Strategies,” was published on the website of the American Journal of Obstetrics and Gynecology. It may be accessed here. Amir Sarayani, a doctoral candidate in the University of Florida College of Pharmacy under Dr. Winterstein’s mentorship, served as the lead author of the paper.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Articles

Latest News

A Trio of Women Selected to Lead Two-Year Colleges in California

Candace B. Jones was named president of Santa Monica College. Star Rivera-Lacey and Christine Holt-McDonald were named chancellor of the Riverside Community College District and the State Center Community College District, respectively.

Elizabeth Dumont Appointed Provost at the University of Vermont

Dr. Dumont has been serving as provost of the University of California, Merced. She is slated to become the next provost of the University of Vermont on January 4.

Tejal Desai to Leave Brown University for New Role at Vanderbilt San Francisco

Dr. Desai has served as dean of the Brown University School of Engineering for the past four years. She will step down from her deanship on December 31 and transition to Vanderbilt University's new campus in San Francisco, where she will direct the Institute of Innovation, Technology, and Translation.

Nefertiti Walker to Lead the University of Massachusetts Boston

Dr. Walker, a professor of sport management, currently serves as senior vice president for academic affairs, student affairs, and equity at UMass Amherst. She is slated to assume new responsibilities as interim chancellor of UMass Boston on February 1.

Three Women Are Among the First Winners of Schmidt Sciences’ New FirstLight Awards

Each awardee will receive as much as $500,000 annually for up to five years to build and lead a team that will seek to advance our understanding of the universe.

Instructional Professor of Quantitative Methods in MAPSS (Open Rank)

The University of Chicago Division of the Social Sciences invites applications for appointment as Instructional Professor at the rank of Assistant, Associate, or Full Professor, with a specialization in quantitative methods, in the Master of Arts Program in the Social Sciences.

Instructional Professor of Sociology in MAPSS (Open Rank)

The University of Chicago Division of the Social Sciences invites applications for appointment as Instructional Professor at the rank of Assistant, Associate, or Full Professor, with a specialization in Sociology, in the Master of Arts Program in the Social Sciences.

Instructional Professor of Psychology in MAPSS (Open Rank)

The University of Chicago Division of the Social Sciences invites applications for appointment as Instructional Professor at the rank of Assistant, Associate, or Full Professor, with a specialization in Psychology, in the Master of Arts Program in the Social Sciences.

Instructional Professor of Political Science in MAPSS (Open Rank)

The University of Chicago Division of the Social Sciences invites applications for appointment as Instructional Professor at the rank of Assistant, Associate, or Full Professor, with a specialization in Political Science, in the Master of Arts Program in the Social Sciences.

Assistant Dean of Academic Affairs (Associate Professor)

The USC Glorya Kaufman School of Dance invites applications for the position of Assistant Dean of Academic Affairs at the rank of Associate Professor with tenure. This is a full-time, tenured faculty appointment with administrative responsibilities, supporting the school's academic mission, curricular excellence, and student success.